Valuation (52%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -6.43 | 25.34 |
| PEG Ratio (TTM) | 0.00 | 0.38 |
| P/S Ratio (TTM) | 0.27 | 3.00 |
| P/B Ratio (TTM) | 0.49 | 4.57 |
| P/FCF Ratio (TTM) | -6.74 | 19.60 |
| Price to 5YR AVG Earnings Ratio | -19.44 | 29.37 |
| Price to 5YR AVG FCF Ratio | 6.84 | 31.90 |
Profitability (5%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -4.76% | 13.74% |
| ROE (TTM) | -7.01% | 25.53% |
| Net Profit Margin (TTM) | -4.21% | 11.25% |
| ROIC 5YR AVG | 2.98% | 35.32% |
Growth (30%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -159.08% | 12.94% | -85.35% |
| Revenue | -3.36% | 9.66% | 3.13% |
| Net Income | -157.02% | 12.30% | -79.65% |
| Cash Flow | -332.88% | 13.42% | 72.84% |
Health (54%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 3.09 | 2.32 |
| Quick Ratio (TTM) | 0.89 | 1.55 |
| D/E Ratio (TTM) | 0.42 | 0.36 |
| Interest Coverage (TTM) | -14.68 | 0.24 |
| Piotroski F-Score | 9 | 7 |
| Altman Z-Score | 2.90 | 6.91 |
| LTL to 5YR AVG FCF | 7.90 | 2.86 |
| Shares Outstanding Growth 5YR AVG | -2.59% | -1.13% |